‘We’d love to use the cash’: Big pharma’s getting ready to spend tax reform dollars on big deals

0 Comments 3 view(s)

BI PRIME: There’s a lot of anticipation for big-ticket pharmaceutical mergers and acquisitions to take off in 2018 as tax reform allows companies to repatriate billions.